Patents Assigned to Discerna Limited
  • Publication number: 20110245093
    Abstract: The present invention relates to a method for producing a protein array starting from DNA (or mRNA) in which a number of native, functional proteins, domains or peptides are produced in parallel by in in vitro synthesis using a cell free system for transcription and translation. The products are immobilised in a gridded format on a surface, using an isolation sequence tag incorporated into the proteins.
    Type: Application
    Filed: January 9, 2009
    Publication date: October 6, 2011
    Applicant: Discerna Limited
    Inventors: Mingyue He, Michael John Taussig
  • Patent number: 6620587
    Abstract: The invention provides a method of displaying nascent proteins or peptides as complexes with eukaryotic ribosomes and the mRNA encoding the protein or peptide following transcription and translation in vitro, of further selecting complexes carrying a particular nascent protein or peptide by means of binding to a ligand, antigen or antibody, and of subsequently recovering the genetic information encoding the protein or peptide from the selected ribosome complex by reverse transcription and polymerase chain reaction (RT-PCR). The RT-PCR recovery step is carried out directly on the intact ribosome complex, without prior dissociation to release the mRNA, thus contributing to maximal efficiency and sensitivity. The steps of display, selection and recovery can be repeated in consecutive cycles. The method is exemplified using single-chain antibody constructs as antibody-ribosome-mRNA complexes (ARMs).
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: September 16, 2003
    Assignee: Discerna Limited
    Inventors: Michael John Taussig, Mingyue He